Y-mAbs Therapeutics Inc.
(YMAB)
undefined
undefined%
At close: undefined
9.43
0.64%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Net Income | -21.43M | -95.57M | -55.27M | -119.34M | -81.03M | -43.27M | -19.16M | -17.06M |
| Depreciation & Amortization | 735.00K | 839.00K | 782.00K | 396.00K | 166.00K | 29.00K | - | - |
| Stock-Based Compensation | 14.45M | 25.60M | 19.33M | 16.14M | 4.66M | 1.97M | 609.00K | 258.00K |
| Other Working Capital | -4.59M | -3.44M | 1.76M | 2.59M | 48.00K | -1.31M | 360.00K | 2.52M |
| Other Non-Cash Items | -1.26M | 3.58M | -62.01M | 8.71M | 43.00K | 97.00K | -63.00K | 2.28M |
| Deferred Income Tax | - | - | 1.90M | -576.00K | - | - | - | - |
| Change in Working Capital | -19.73M | -10.37M | -7.28M | 3.44M | 2.67M | -47.00K | 2.75M | 3.35M |
| Operating Cash Flow | -27.23M | -75.92M | -102.56M | -91.23M | -73.50M | -41.23M | -15.87M | -11.17M |
| Capital Expenditures | - | - | -967.00K | -175.00K | -1.97M | -234.00K | - | - |
| Acquisitions | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | - | 62.01M | -2.61M | - | - | - | - |
| Investing Cash Flow | - | - | 61.04M | -2.79M | -1.97M | -234.00K | - | - |
| Debt Repayment | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | -366.00K |
| Dividend Paid | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 100.00K | 84.00K | 589.00K | 2.00M | - | -1.00M | -258.00K | - |
| Financial Cash Flow | 100.00K | 84.00K | 108.31M | 2.00M | 134.70M | 98.76M | 89.59M | 18.97M |
| Net Cash Flow | -27.13M | -75.80M | 66.93M | -92.50M | 59.27M | 57.36M | 73.61M | 7.81M |
| Free Cash Flow | -27.23M | -75.92M | -103.52M | -91.41M | -75.46M | -41.46M | -15.87M | -11.17M |